Cocooncenter has been acquired by Groupe Pharmacie Lafayette
The shareholders of Cocooncenter have sold the company to Groupe Pharmacie Lafayette.
Founded in 2005, Cocooncenter offers an assortment of parapharmaceutical products from the leading laboratory brands, dedicated to well-being. The offer includes more than 720 brands and more than 24,000 references selected by a team of specialists to guarantee product quality. Cocooncenter has put customer relations at the heart of its strategy with a dedicated service providing personalized advice and satisfaction monitoring.
Groupe Pharmacie Lafayette, owned by the fund Five Arrows Principal Investments, has been working since 2005 to make healthcare accessible to all through its four brands: Pharmacie Lafayette, Parapharmacie Lafayette, Optique Lafayette and Lafayette Medical. The group has developed a network of pharmacies that offer low prices on very wide range of products, as well as professional advice.
Oaklins’ team in France acted as advisor to the shareholders of Cocooncenter in this transaction.
Talk to the deal team
Managing PartnerParis, France
Palmatum has raised its first round to build a major commercial facility
The founder of Palmatum has raised US$30 million in order to build and operate Montreal’s major and most innovative commercial B2C trade floor – 150,000 sqft dedicated to garden and home interior.Learn more
Grupo BC has acquired Lexer
The owners of Lexer have sold the company to Grupo BC. With this acquisition, Grupo BC consolidates its position as provider of critical processes to the main Spanish financial institutions and offers the potential for Lexer to expand in Latin America while continuing to consolidate the Spanish debt collection sector.Learn more
Gilde Healthcare has invested in Tandarts Today
Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.Learn more